GERON CORP (GERN)

↓ Download CSV

CIK 0000886744 · Nasdaq · Pharmaceutical Preparations

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

Key ratios (FY2025)

-37.0%
Return on equity
Metric (FY)2025202420232022202120202019201820172016
Revenue$237.0K$596.0K$1.39M$253.0K$460.0K$1.07M$1.06M$6.16M
Operating Income-$68.58M-$173.73M-$193.94M-$138.55M-$114.00M-$76.91M-$72.50M-$31.07M-$29.25M-$30.65M
Net Income-$83.50M-$174.57M-$184.13M-$141.90M-$116.11M-$75.62M-$68.55M-$27.02M-$27.92M-$29.54M
EPS (Diluted)$-0.13$-0.27$-0.32$-0.37$-0.35$-0.28$-0.18$-0.19
Total Assets$570.54M$593.78M$394.08M$190.57M$226.03M$270.73M$165.52M$185.28M$110.31M$130.25M
Total Liabilities$344.67M$313.46M$146.13M$110.58M$99.62M$59.78M$30.36M
Shareholders' Equity$225.87M$280.32M$247.95M$80.00M$126.42M$210.95M$135.16M$177.73M$103.80M$122.38M
Cash & Equivalents$77.56M$79.02M$70.02M$56.84M$34.87M$9.93M$13.64M$10.57M$16.34M$12.81M
Operating Cash Flow-$111.04M-$218.62M-$167.74M-$127.38M-$95.56M-$66.65M-$43.83M-$21.01M-$20.56M-$18.37M
Capital Expenditures$680.0K$830.0K$431.0K$207.0K$401.0K$413.0K$16.0K$57.0K
Shares Outstanding639.86M606.39M544.91M390.26M323.73M310.57M199.81M186.39M159.88M159.16M